First-in-human trial of tocilizumab in combination with a standard induction chemotherapy in newly diagnosed acute myeloid leukemia patients: The phase 1 TOCILAM study.

被引：0
|
作者：
Peterlin, Pierre
Garnier, Alice
Le Bourgeois, Amandine
Guillaume, Thierry
Jullien, Maxime
Planche, Lucie
Gaschet, Joelle
Chevallier, Patrice
机构：
[1] CHU Nantes, Serv Hematol Clin, Nantes, France
[2] CHU Nantes, Hotel Dieu HME, Nantes, France
[3] Dept Hosp Ctr, Clin Res Ctr, La Roche Sur Yon, France
[4] Univ Angers, Nantes Univ, CNRS, Inserm,CRCI2NA, Nantes, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7028
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial
    Peterlin, Pierre
    Garnier, Alice
    Le Bourgeois, Amandine
    Guillaume, Thierry
    Le Bris, Yannick
    Theisen, Olivier
    Bene, Marie C.
    Eveillard, Marion
    Rimbert, Marie
    Jullien, Maxime
    Planche, Lucie
    Gaschet, Joelle
    Chevallier, Patrice
    ECLINICALMEDICINE, 2023, 64
  • [2] Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia
    Altman, Jessica K.
    Foran, James M.
    Pratz, Keith W.
    Trone, Denise
    Cortes, Jorge E.
    Tallman, Martin S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (02) : 213 - 221
  • [3] A Phase 1 Study of Gilteritinib in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Final Study Results
    Pratz, Keith W.
    Cherry, Mohamad
    Podoltsev, Nikolai A.
    Altman, Jessica K.
    Perl, Alexander E.
    Cooper, Brenda W.
    Jurcic, Joseph G.
    Lin, Tara L.
    Schiller, Gary J.
    Wu, Ruishan
    Hill, Jason E.
    Gill, Stanley C.
    James, Angela
    Rich, Elizabeth Shima
    Hasabou, Nahla
    Levis, Mark J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S230 - S230
  • [4] A Phase I Trial of Sirolimus with "7&3" Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
    Palmisiano, Neil
    Jeschke, Grace
    Wilde, Lindsay
    Alpdogan, Onder
    Carabasi, Matthew
    Filicko-O'Hara, Joanne
    Grosso, Dolores
    Klumpp, Thomas
    Martinez, Ubaldo
    Wagner, John
    Carroll, Martin P.
    Perl, Alexander
    Kasner, Margaret
    CANCERS, 2023, 15 (21)
  • [5] Preliminary Results from a Phase 1 Study of Gilteritinib in Combination with Induction and Consolidation Chemotherapy in Subjects with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Pratz, Keith
    Cherry, Mohamad
    Altman, Jessica K.
    Cooper, Brenda W.
    Cruz, Jose Carlos
    Jurcic, Joseph G.
    Levis, Mark J.
    Lin, Tara L.
    Perl, Alexander E.
    Podoltsev, Nikolai A.
    Schiller, Gary J.
    Liu, Chaofeng
    Bahceci, Erkut
    BLOOD, 2017, 130
  • [6] Updated Results from a Phase 1 Study of Gilteritinib in Combination with Induction and Consolidation Chemotherapy in Subjects with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Pratz, Keith W.
    Cherry, Mohamad
    Altman, Jessica K.
    Cooper, Brenda
    Cruz, Jose Carlos
    Jurcic, Joseph G.
    Levis, Mark J.
    Lin, Tara L.
    Perl, Alexander E.
    Podoltsev, Nikolai A.
    Schiller, Gary J.
    Liu, Chaofeng
    Bahceci, Erkut
    BLOOD, 2018, 132
  • [7] Pracinostat combined with azacitidine in newly diagnosed adult acute myeloid leukemia (AML) patients unfit for standard induction chemotherapy: PRIMULA phase III study
    Garcia-Manero, Guillermo
    Kazmierczak, Maciej
    Wierzbowska, Agnieszka
    Fong, Chun Yew
    Keng, Michael K.
    Ballinari, Gianluca
    Scarci, Francesco
    Ades, Lionel
    LEUKEMIA RESEARCH, 2024, 140
  • [8] A Phase 1 Clinical Trial of Selinexor in Combination with Decitabine in Patients with Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia
    Bhatnagar, Bhavana
    Klisovic, Rebecca B.
    Walker, Alison R.
    Vasu, Sumithra
    Mims, Alice S.
    Walsh, Katherine J.
    Behbehani, Gregory K.
    Blachly, James S.
    Vittorio, Molly
    Zhao, Qiuhong
    Ruppert, Amy S.
    Orwick, Shelley
    Ranganathan, Parvathi
    Byrd, John C.
    Blum, William
    Garzon, Ramiro
    BLOOD, 2016, 128 (22)
  • [9] Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
    Cherry, Evan M.
    Abbott, Diana
    Amaya, Maria
    McMahon, Christine
    Schwartz, Marc
    Rosser, Julie
    Sato, Audrey
    Schowinsky, Jeffrey
    Inguva, Anagha
    Minhajuddin, Mohd
    Pei, Shanshan
    Stevens, Brett
    Winters, Amanda
    Jordan, Craig T.
    Smith, Clayton
    Gutman, Jonathan A.
    Pollyea, Daniel A.
    BLOOD ADVANCES, 2021, 5 (24) : 5565 - 5573
  • [10] Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results from Two Phase 1 Trials in Japan and China
    Qi, Junyuan
    Choi, Ilseung
    Ota, Shuichi
    Ichikawa, Satoshi
    Fujishima, Naohito
    Iida, Hiroatsu
    Sugiura, Isamu
    Sugiura, Koichi
    Murata, Yasuharu
    Inoue, Hiroyuki
    Ohwada, Shoichi
    Wang, Jianxiang
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (05): : 560 - 571
12345